Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

NCT03130439 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Breast Cancer

Interventions

DRUG: Abemaciclib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]